Medicare Enrolled

Dr. Steven McGrath, M.D.

Pain Medicine · Cherry Hill, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1401 MARLTON PIKE E STE 29, Cherry Hill, NJ 08034
8568435870
In practice since 2011 (15 years)
NPI: 1992091888 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McGrath from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGrath? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McGrath

Dr. Steven McGrath is a pain medicine specialist in Cherry Hill, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. McGrath performed 1,546 Medicare services across 862 unique beneficiaries.

Between the years covered by Open Payments, Dr. McGrath received a total of $5,442 from 51 pharmaceutical and/or device companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McGrath is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 27% volume in NJ $5,442 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,546
Medicare services
Top 27% in NJ for pain medicine
862
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
626 $67 $500
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
299 $96 $800
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
169 $61 $901
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
125 $111 $840
Injection, methylprednisolone acetate, 40 mg 70 $5 $30
Brachial plexus injection with anesthetic and/or steroid
An injection of an anesthetic agent and/or steroid into the brachial plexus nerve bundle in the arm.
60 $57 $1,989
Anesthesia for total shoulder joint replacement
This procedure covers the administration of anesthesia during an open or endoscopic total shoulder joint replacement surgery.
57 $172 $1,627
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
34 $127 $850
Anesthesia for endoscopic procedure on esophagus, stomach, or upper small bowel
Administration of anesthesia during an endoscopic procedure involving the esophagus, stomach, or upper small bowel.
30 $60 $569
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
25 $189 $2,520
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
20 $80 $450
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
19 $153 $1,680
Anesthesia for skin procedures on arms, legs, or front body
This code covers anesthesia services provided for surgical procedures performed on the skin of the arms, legs, or anterior trunk.
12 $78 $743
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
9.7% medium
86.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,442
Total received (2018-2024)
Avg $777/year across 7 years
Top 18% in NJ for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
323
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,442 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$777
2023
$656
2022
$481
2021
$636
2020
$724
2019
$934
2018
$1,233

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SCILEX PHARMACEUTICALS INC.
$194
Boston Scientific Corporation
$116
Collegium Pharmaceutical, Inc.
$114
SI-BONE, INC.
$70
PROTEGA PHARMACEUTIALS INC
$64
Medtronic, Inc.
$57
Vertos Medical, Inc.
$43
Abbott Laboratories
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Nevro Corp.
$19
IBSA Pharma Inc.
$15
SPR Therapeutics, Inc
$13
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$844
Collegium Pharmaceutical, Inc.
$608
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$402
Scilex Pharmaceuticals Inc.
$352
SCILEX PHARMACEUTICALS INC.
$340
Vertos Medical, Inc.
$235
PFIZER INC.
$220
Daiichi Sankyo Inc.
$220
Boston Scientific Corporation
$196
SI-BONE, INC.
$180
Nevro Corp.
$171
BOSTON SCIENTIFIC CORPORATION
$137
BioDelivery Sciences International, Inc.
$114
Kowa Pharmaceuticals America, Inc.
$103
Horizon Therapeutics plc
$100
Shionogi Inc
$91
Sentynl Therapeutics, Inc.
$84
RedHill Biopharma Inc.
$68
PROTEGA PHARMACEUTIALS INC
$64
IBSA Pharma Inc.
$58
Medtronic, Inc.
$57
US WorldMeds, LLC
$47
Kaleo, Inc.
$43
Zyla Life Sciences, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$43
Almatica Pharma LLC
$41
Teva Pharmaceuticals USA, Inc.
$40
West Therapeutics Development, LLC
$37
USWM, LLC
$36
Medtronic USA, Inc.
$35
Flexion Therapeutics, Inc.
$35
Valinor Pharma, LLC
$32
Biohaven Pharmaceutical Holding Company Ltd.
$28
GRT US Holding, Inc.
$28
Horizon Pharma plc
$26
SANOFI-AVENTIS U.S. LLC
$26
Assertio Therapeutics, Inc.
$26
Zyla Life Sciences
$24
Purdue Pharma L.P.
$24
Stimwave Technologies Incorporated
$22
SI-BONE, Inc.
$20
ABBVIE INC.
$17
PROTEGA PHARMACEUTIALS LLC
$15
Biohaven Pharmaceuticals, Inc.
$15
Azurity Pharmaceuticals, Inc.
$15
Pacira Pharmaceuticals Incorporated
$14
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
SPR Therapeutics, Inc
$13
Iroko Pharmaceuticals, LLC
$13
Hikma Pharmaceuticals USA
$13
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AJOVY · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · DUEXIS · Evzio · FLECTOR · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · General - Pain Management · Gralise · Horizant · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Iovera · Kloxxado · LICART · LUCEMYRA · LYRICA · Lazanda · Levorphanol · Licart · Lucemyra · Lucemyra/Lofexidine · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · Octrode SCS Leads · Omnia · PENNSAID · PROCLAIM · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ROXYBOND · Roxybond · SCS IPGs · SCS leads · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SYMPROIC · SYNVISC-ONE · Seglentis · Senza · Senza Spinal Cord Stimulation System · Symproic · Tirosint · VIMOVO · VIVLODEX · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Cherry Hill?
Compare pain medicines in the Cherry Hill area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
84
Per 100K population
16.0
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McGrath is a clinical cardiology specialist, with above-average Medicare volume (top 27% in NJ), with low-engagement industry engagement in the top 18% of NJ peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McGrath experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. McGrath performed 626 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGrath receive payments from pharmaceutical companies?
Yes. Dr. McGrath received a total of $5,442 from 51 companies across 323 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGrath's costs compare to other pain medicines in Cherry Hill?
Dr. McGrath's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGrath) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →